e.salinas
Submits third-party assay reports on material purchased directly. Based in Bologna.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.92%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041486 | PT-141 (Bremelanotide) | QYB | QYB-2607-L5615 | Nordanalyt | 2026-Q3 | 99.62 | 3.82 | 104.9 | Supplier-supplied | 0 | PASS |
| AX-2026-042569 | GHK-Cu | ERP | ERP-2604-K8139 | Medutest | 2026-Q2 | 98.34 | 6.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018503 | MOTS-c | WWB | WWB-2505-G2801 | Janoshik | 2025-Q3 | 99.38 | 3.33 | 94.7 | Supplier-supplied | 0 | PASS |
| AX-2025-019770 | Semaglutide | HJ | HJ-2504-Y4203 | Medutest | 2025-Q2 | 98.55 | 4.93 | 101.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020282 | Enclomiphene citrate | MKM | MKM-2408-L2880 | Janoshik | 2025-Q1 | 98.03 | 4.35 | 107.4 | Buyer-sourced | 1 | FAIL |
| AX-2025-020069 | BPC-157 | ERP | ERP-2410-T8236 | Medutest | 2025-Q1 | 98.92 | 6.15 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2024-004462 | MOTS-c | FGP | FGP-2411-A1460 | Medutest | 2024-Q4 | 99.93 | 5.41 | — | Supplier-supplied | 0 | PASS |
| AX-2024-005049 | PT-141 (Bremelanotide) | MKM | MKM-2406-H2712 | Janoshik | 2024-Q3 | 98.38 | 5.99 | 91.6 | Supplier-supplied | 0 | FAIL |
| AX-2024-004644 | AOD-9604 | TFC | TFC-2402-L6506 | Janoshik | 2024-Q2 | 99.74 | 5.61 | — | Supplier-supplied | 1 | MARGINAL |